Your browser doesn't support javascript.
Discussion on feasibility of electronic informed consent in drug clinical trials.
Drug Evaluation Research ; 44(7):1568-1572, 2021.
Artigo em Chinês | EMBASE | ID: covidwho-20238692
ABSTRACT
With the development of science and technology, electronic information technology has penetrated into many aspects of society now. Electronic informed consent is an effective way to adapt to development clinical trial. China is still at an early stage in this field. Affected by the outbreak of COVID-19 in 2020, the demand for electronic informed consent in clinical trial has become more urgent. Based on my own work experience, the author wants to analyze the problems in the traditional informed consent process and the current situations of electronic informed consent in China and explores the feasibility of electronic informed consent in clinical trials.Copyright © 2021 Drug Evaluation Research. All rights reserved.
Palavras-chave

Texto completo: Disponível Coleções: Bases de dados de organismos internacionais Base de dados: EMBASE Tipo de estudo: Estudo experimental / Estudo prognóstico / Ensaios controlados aleatorizados Idioma: Chinês Revista: Drug Evaluation Research Ano de publicação: 2021 Tipo de documento: Artigo

Similares

MEDLINE

...
LILACS

LIS


Texto completo: Disponível Coleções: Bases de dados de organismos internacionais Base de dados: EMBASE Tipo de estudo: Estudo experimental / Estudo prognóstico / Ensaios controlados aleatorizados Idioma: Chinês Revista: Drug Evaluation Research Ano de publicação: 2021 Tipo de documento: Artigo